Business Context and Reporting Period
Company: Bruker BioSciences Corporation
Filing Type: Form 8-K (Current Report)
Report Date: August 3, 2004
Reporting Period: Three and six months ended June 30, 2004
Context: The company announced its results of operations for the specified periods via a press release attached as Exhibit 99.1.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These details are contained within the attached press release (Exhibit 99.1) and are not explicitly stated in the body of this Form 8-K.
Material Changes
The filing text does not provide specific data regarding material changes versus prior comparable periods. Investors must refer to the attached press release for comparative analysis.
Guidance, Outlook, and Risks
Management Commentary: The filing incorporates the press release by reference but does not summarize specific management commentary, guidance, or outlook within the text provided.
Risks and Contingencies: No specific risks or contingencies are detailed in the filing text.
Legal Disclaimer: The information furnished in this Form 8-K and Exhibit 99.1 is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and is not subject to the liabilities of that section.
Key Facts for Investor Verification
- Verify the specific financial results (revenue, net income, cash flow) in the attached press release (Exhibit 99.1) as they are not listed in the main filing text.
- Confirm the company's forward-looking guidance and operational outlook from the press release.
- Note that the financial data in this filing is furnished but not "filed" under Section 18 of the Exchange Act, limiting liability exposure for the registrant regarding this specific document.
- Check the company's principal executive office address: 40 Manning Road, Billerica, MA 01821.